Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
Clinical Ophthalmology, 07/02/09
Nakamura Y et al. - Dorzolamide bid or tid and brinzolamide bid when combined with latanoprost therapy elicited significant IOP reduction for 24 hours. It is rational to consider patients’ preference of therapeutic regimen especially long-term users such as those with glaucoma.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Patients' preferences for positioning during phaco-emulsification under topical-intracameral anaesthesia
Clinical and Experimental Ophthalmology, 10/13/09
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Today in Glaucoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Natural History of Open-Angle Glaucoma
Ophthalmology, 10/28/09
New devices in glaucoma surgery
Expert Review of Ophthalmology, 10/19/09
Article Search
Sponsor


See Latest Articles


